Impact of Mindful Self-Compassion Therapy on Self Harm Behaviors, Emotional Regulation and Quality of Life Among Patients With Borderline Personality Disorder
1 other identifier
interventional
60
1 country
2
Brief Summary
The primary purpose of the study is to investigate whether Mindful Self-Compassion (MSC) therapy can significantly reduce self-harm behaviors, improve emotional regulation, and enhance the quality of life in individuals diagnosed with Borderline Personality Disorder (BPD). The study aims to contribute to the existing literature by providing robust evidence on the efficacy of MSC therapy for BPD, which could inform clinical practices and improve treatment outcomes
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Sep 2024
2 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 21, 2024
CompletedFirst Submitted
Initial submission to the registry
November 19, 2024
CompletedFirst Posted
Study publicly available on registry
November 21, 2024
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 30, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 30, 2025
CompletedSeptember 2, 2025
August 1, 2025
1.3 years
November 19, 2024
August 29, 2025
Conditions
Outcome Measures
Primary Outcomes (1)
World Health Organization Quality of Life Scale Urdu Version
It has 26 items and four domains: physical health (7 items), psychological health (6 items), social relationships (3 items), and environmental health (8 items); it also contains quality of life and general health items. The minimum value is 26 and the maximum value is 130. Higher scores on the scale indicate higher quality of life and low scores indicate low quality of life.
3 months
Study Arms (2)
Experimental
EXPERIMENTALWho receives intervention i.e. Mindful Self Compassion Therapy
Waitlist Control
ACTIVE COMPARATORWho would receive intervention after study completion
Interventions
Mindful Self-Compassion (MSC) therapy is an 8-week program blending mindfulness and self-compassion to improve emotional resilience and well-being. Week 1: Introduction - Learn the basics of mindfulness, self-compassion, and reframing self-critical thoughts with kindness. Week 2: Mindfulness - Practice observing thoughts and emotions without judgment to build self-awareness. Week 3: Self-Kindness - Develop skills to treat yourself with warmth and care during difficult times. Week 4: Common Humanity - Explore shared human experiences to reduce feelings of isolation. Week 5: Working with Challenges - Learn strategies to respond compassionately to emotional pain. Week 6: Growing Compassion - Deepen compassion for yourself and others through guided exercises. Week 7: Resilience Building - Strengthen coping skills and foster emotional flexibility. Week 8: Integration - Consolidate skills to maintain self-compassion in daily life.
Eligibility Criteria
You may qualify if:
- \. First time diagnosed non-hospitalized patients of Borderline Personality Disorder.
- \. Patients of Borderline Personality Disorder experiencing psychological distress,low level of quality of life, social support, emotional dysregulation would be included.
- \. Borderline Personality Disorder patients with age 18 years and above (both gender) from outpatient department (OPD) 4. Borderline personality patients who would be able to understand Urdu language and can give the informed consent
You may not qualify if:
- Hospitalized patients of Borderline Personality
- Patients with Borderline Personality having other chronic co-morbid diseases such as cancer, cognitive deficits, and other chronic psychological disorders.
- Patients with Borderline Personality younger than 18 years of age
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (2)
Commandant Afimh
Rawalpindi, Punjab Province, 46000, Pakistan
Farid Family Hospital
Rawalpindi, Punjab Province, 46000, Pakistan
Related Links
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Asma Mansoor, PhD Scholar
Fatima Jinnah Women University, Rawalpindi, Pakistan
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Masking Details
- Double
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Principal Investigator
Study Record Dates
First Submitted
November 19, 2024
First Posted
November 21, 2024
Study Start
September 21, 2024
Primary Completion
December 30, 2025
Study Completion
December 30, 2025
Last Updated
September 2, 2025
Record last verified: 2025-08
Data Sharing
- IPD Sharing
- Will not share
Due to ethical concerns the data will not be shared. All research findings will be published in aggregate form maintaining patient anonymity